worldwide offices | contact | help | site map

Novartis Pharmaceuticals Corporation - A site intended for US audiences

 

 

 

Diseases & Conditions

PrintTell a FriendtextDecrease text sizeIncrease text size

Back to Index of Diseases & Conditions by Therapeutic Area

Cystic Fibrosis

Understanding this condition

Cystic fibrosis (CF) is a life-threatening disorder that causes severe lung damage and nutritional deficiencies.

An inherited condition, cystic fibrosis affects the cells that produce mucus, sweat, saliva and digestive juices. Normally, these secretions are thin and slippery, but in cystic fibrosis, a defective gene causes them to become thick and sticky. Instead of acting as a lubricant, the secretions plug up tubes, ducts and passageways, especially in the pancreas and lungs.

Respiratory failure is the most dangerous consequence of cystic fibrosis. Also, the secretions block pancreatic enzymes that help digest fats and proteins, and they prevent your body from absorbing key vitamins.

Treatments for cystic fibrosis are aimed at relieving symptoms and complications.

Source: MayoClinic.com

 

Back to Index of Diseases & Conditions
 

OUR PRODUCTS

Products

Novartis is recognized worldwide for bringing to market innovative medicines with improved efficacy and fewer side-effects.

ACCESS TO MEDICINES

Access to Medicines

Novartis puts patients first. We want to create value for all patients, including those who cannot afford treatment. That is why we established Patient Assistance Now, a resource that allows you to access programs that may help you pay for your Novartis medicines.

PATIENT ASSISTANCE PROGRAMS

Patient Assistance Programs

Through our Patient Assistance Programs, we are committed to providing access to our medications for those most in need.